Infection‐Related Hospitalization and Incident Heart Failure in MarketScan: A Case‐Crossover Study

作者：Rebecca Molinsky, Pamela L. Lutsey, Rob F. Walker, Wendy Wang, M. Yuzefpolskaya, Katherine Giorgio, David M. Vock, Richard F. MacLehose, P.C. Colombo, Ryan T. Demmer · 发表于：Journal of the American Heart Association · 年份：2025 · DOI：10.1161/jaha.123.039123 · 被引用次数：3 · 研究领域：Heart Failure Treatment and Management、Chronic Disease Management Strategies、Sepsis Diagnosis and Treatment

Background Heart failure (HF) is a growing public health burden. Systemic inflammation is commonly observed in patients with HF and believed to be related to disease pathogenesis. Infection is a potential acute trigger of chronic inflammation. Our objective was to examine the relationship between infection‐related hospitalization (IRH) and HF. Methods and Results We studied beneficiaries with at least 15 months of continuous enrollment in the US‐based MarketScan databases during 2013 to 2019. We included n=152 008 patients with an inpatient or outpatient HF International Classification of Diseases, Ninth Revision/Tenth Revision ( ICD‐9/10 ) code in the primary position. Among patients with HF, IRH was identified using select ICD‐9/10 codes. We used a case‐crossover design to compare the frequency of IRH occurring within 3 months of the index HF event (case period) versus the frequency of IRH occurring 12 to 15 months before the index HF event (control period). Logistic models regressed the log‐odds of having an IRH during the case versus control periods; odds ratios (ORs; 95% CIs) are presented. Among 152 008 beneficiaries, 53% were male with a mean±SD age of 56(±11) years. The odds of having an IRH during the case (versus control) period was elevated for both the 3‐month case period (OR, 4.39 [95% CI, 4.18–4.60]), and 1‐month case period (OR, 7.39 [95% CI, 6.88–7.94]), after adjusting for the total number of hospitalizations. This relationship persisted across different type...